Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-15

Clinical Trial Update: Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy and safety of HYDEAL-D vaginal pessaries for vulvovaginal atrophy in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDEAL-D vaginal pessaries

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Vulvovaginal Atrophy | NA | Status: COMPLETED